Business ❯ Healthcare

Pharmaceutical Companies

Novo Nordisk Clinical Trials Eli Lilly Vaccine Development Clinical Research Organizations Sanofi Pricing Agreements Investment Nectar Lifesciences Market Competition Hims & Hers AbbVie Inc. Clinical Research Pricing Strategies Product Portfolio Laboratories Market Reactions Market Analysis Oncology Treatments GSK Processa Pharmaceuticals Stock Market Syndax Pharmaceuticals

3 ARTICLES

3w ago

Lilly Sues Six U.S. Sellers Over Black‑Market Sales of Unapproved Retatrutide

The company says it referred more than 200 people and entities to regulators to stop unsafe illicit GLP‑1 sales ahead of a planned Q1 2027 U.S. biologics filing for retatrutide.

22 ARTICLES

last mo.

Jasper Therapeutics Investors Face Lead Plaintiff Deadline in Securities Class Action

12 ARTICLES

11mo ago

Trump Pledges Sharp Cuts to GLP-1 Drug Prices as Novo, Lilly Shares Slide

4 ARTICLES

11mo ago

Metsera’s Obesity Drug Posts 14% Placebo-Adjusted Weight Loss, Bolstering Pfizer Buyout Case

Pharmaceutical Companies

Lilly Sues Six U.S. Sellers Over Black‑Market Sales of Unapproved Retatrutide

AstraZeneca in Talks With Bristol Myers on Potential $400 Billion Merger

AbbVie to Buy Apogee for About $10.9 Billion to Add Clinical-Stage IL-13 Drug

For Third Time, FDA Rejects Aldeyra’s Dry-Eye Drug Reproxalap Over Efficacy

Eli Lilly Becomes First Health Care Company Valued at $1 Trillion

Jasper Therapeutics Investors Face Lead Plaintiff Deadline in Securities Class Action

Trump Pledges Sharp Cuts to GLP-1 Drug Prices as Novo, Lilly Shares Slide

Metsera’s Obesity Drug Posts 14% Placebo-Adjusted Weight Loss, Bolstering Pfizer Buyout Case